The Oncolytic Adenovirus DNX-2401 Has Antitumor Activity in Glioblastoma

    Cancer Discovery
    |February 25, 2018
    PubMed

    Insights

    DNX-2401 is a safe experimental cancer therapy that shows lasting effectiveness in patients with recurrent glioma. This early trial indicates promising results for treating this aggressive brain tumor.

    Area of Science:

    • Neuro-oncology
    • Oncolytic virotherapy
    • Clinical trials

    Background:

    • Recurrent glioma presents a significant unmet medical need due to limited effective treatment options.
    • Phase I clinical trials are essential for evaluating the safety and preliminary efficacy of novel cancer therapies.
    • DNX-2401 is an oncolytic virus designed to selectively infect and destroy cancer cells while stimulating an anti-tumor immune response.

    Discussion:

    • The phase I trial demonstrated a favorable safety profile for DNX-2401 in patients with recurrent glioma.
    • Durable responses were observed, suggesting the potential for long-term disease control.
    • The findings warrant further investigation into the efficacy of DNX-2401 in larger patient cohorts.

    Key Insights:

    • DNX-2401 exhibits an acceptable safety profile in patients with recurrent glioma.
    • The therapy achieved durable clinical responses, indicating anti-tumor activity.
    • This study provides a foundation for future clinical development of DNX-2401.

    Outlook:

    • Further clinical trials, including phase II and III studies, are planned to confirm the efficacy and safety of DNX-2401.
    • DNX-2401 may represent a novel therapeutic strategy for patients with recurrent glioma.
    • Research will focus on optimizing dosing, delivery, and patient selection for DNX-2401 therapy.

    Related Concept Videos

    Co-activators and Co-repressors02:04

    Co-activators and Co-repressors

    Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
    8.7K
    tRNA Activation02:26

    tRNA Activation

    Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
    23.1K
    Activation Energy01:26

    Activation Energy

    Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
    87.2K
    Eukaryotic Transcription Activators02:42

    Eukaryotic Transcription Activators

    Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
    The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
    12.9K
    Secondary Active Transport01:55

    Secondary Active Transport

    One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
    138.3K
    Primary Active Transport01:47

    Primary Active Transport

    In contrast to passive transport, active transport involves a substance being moved through membranes in a direction against its concentration or electrochemical gradient. There are two types of active transport: primary active transport and secondary active transport. Primary active transport utilizes chemical energy from ATP to drive protein pumps that are embedded in the cell membrane. With energy from ATP, the pumps transport ions against their electrochemical gradients—a direction...
    201.0K